Auro Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE292C01011
  • NSEID:
  • BSEID: 530233
INR
247.60
5.9 (2.44%)
BSENSE

Nov 20

BSE+NSE Vol: 2.9 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Kimia Bioscien.
Bal Pharma
Medico Remedies
Quest Laborato.
Syschem (India)
Sotac Pharma.
Natural Capsules
Auro Labs.
Parnax Lab
Guj. Inject(Ker)
Himalaya Nutrave
Why is Auro Laboratories Ltd ?
1
Weak Long Term Fundamental Strength with a 8.19% CAGR growth in Operating Profits over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 4.47 times
2
Stock is technically in a Mildly Bearish range
  • Multiple factors for the stock are Mildly Bearish like MACD, KST and DOW
3
With ROCE of 6.4, it has a Expensive valuation with a 2 Enterprise value to Capital Employed
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -4.01%, its profits have risen by 398.1% ; the PEG ratio of the company is 0.1
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Auro Labs. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Auro Labs.
-4.01%
-0.09
44.56%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-2.47%
EBIT Growth (5y)
8.19%
EBIT to Interest (avg)
3.75
Debt to EBITDA (avg)
5.20
Net Debt to Equity (avg)
1.33
Sales to Capital Employed (avg)
0.84
Tax Ratio
16.77%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
13.36%
ROE (avg)
9.20%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
30
Industry P/E
40
Price to Book Value
3.34
EV to EBIT
19.86
EV to EBITDA
14.81
EV to Capital Employed
2.01
EV to Sales
5.17
PEG Ratio
0.07
Dividend Yield
NA
ROCE (Latest)
6.45%
ROE (Latest)
11.29%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

23What is working for the Company
PAT(Latest six months)

At Rs 2.22 cr has Grown at 263.93%

OPERATING PROFIT TO INTEREST(Q)

Highest at 2.84 times

NET SALES(Q)

Highest at Rs 13.94 cr

PBT LESS OI(Q)

Highest at Rs 1.63 cr.

-6What is not working for the Company
OPERATING CF(Y)

Lowest at Rs 2.11 Cr

INTEREST(9M)

At Rs 4.25 cr has Grown at 53.99%

Loading Valuation Snapshot...
Here's what is working for Auro Labs.
Profit After Tax (PAT) - Latest six months
At Rs 2.22 cr has Grown at 263.93%
Year on Year (YoY)
MOJO Watch
PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
At Rs 13.94 cr has Grown at 51.4% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 9.21 Cr
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Operating Profit to Interest - Quarterly
Highest at 2.84 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales - Quarterly
Highest at Rs 13.94 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 1.63 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Here's what is not working for Auro Labs.
Interest - Nine Monthly
At Rs 4.25 cr has Grown at 53.99%
over preceding nine months period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Operating Cash Flow - Annually
Lowest at Rs 2.11 Cr and Fallen
each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (Rs Cr)